期待您的支持
Since specific details regarding your personal experience (e.g., specific products purchased, dates, or individual staff names) were not provided, I have designed this as a positive, comprehensive corporate review. This draft highlights the most common strengths associated with established pharmaceutical distributors in Peru.
You can adjust the rating or specific details to better match your actual experience.
Review Title: Reliable Pharmaceutical Distribution and Professional Service in Peru
Rating: ⭐⭐⭐⭐⭐ (5/5)
Review Body:
I am writing to provide a formal review of my experience with D & M Pharma Peru Sac. As a professional in the healthcare and pharmaceutical sector, finding a distributor that balances logistical efficiency with product integrity is essential. D & M Pharma has consistently demonstrated a high level of competence in these areas.
Product Portfolio and Quality D & M Pharma Peru Sac offers a robust portfolio of pharmaceutical products. Whether sourcing essential medicines or specialized supplies, they have proven to be a reliable link in the supply chain. The quality of the products received has always met the necessary regulatory standards, providing peace of mind regarding patient safety and care.
Logistics and Delivery In the pharmaceutical industry, timing is critical. I was impressed with the company’s logistical capabilities. Deliveries were handled professionally, adhering to cold-chain requirements where necessary, and arrived within the estimated timeframes. Their ability to navigate local distribution challenges in Peru speaks to their operational maturity.
Customer Service and Professionalism The administrative and sales teams are a standout asset for this company. Communication is clear, responsive, and courteous. They are knowledgeable about their inventory and regulatory compliance, making the procurement process seamless. It is refreshing to work with a team that prioritizes customer support as much as product distribution.
Conclusion Overall, D & M Pharma Peru Sac is a solid partner for medical institutions, pharmacies, and healthcare providers in Peru. They combine industry expertise with reliable service. I would highly recommend them to any organization seeking a dependable pharmaceutical supplier. d amp m pharma peru sac
Pros:
Cons:
For D&M Pharma Perú S.A.C., a pharmaceutical wholesaler and representative founded in 2006 that specializes in respiratory and dermatological products, a high-impact feature would be a "Pharma-Direct Traceability Portal." Feature: Pharma-Direct Traceability Portal
Since D&M Pharma focuses on being a strategic bridge between international manufacturers (like Laboratorio Cassará) and the Peruvian market, this feature would enhance their core commitment to quality and transparency.
Lot-Specific Verification: A digital tool allowing healthcare providers and pharmacies to scan a code on the product packaging (such as their respiratory or aerosoltherapy lines) to instantly verify the batch's origin and compliance with DIGEMID (Peru's regulatory authority) standards.
Real-time Pharmacovigilance Integration: An easy-access button for doctors to report adverse reactions directly to D&M Pharma's dedicated pharmacovigilance team, which is already a highlighted contact point on their Official Website.
Dynamic Inventory for Clinicians: A "Check Local Availability" map for doctors to see which nearby pharmacies currently have stock of specialized lines like Cassará, ensuring patients can fill their prescriptions without delay. Why this fits:
D&M Pharma operates in a niche involving 32 employees in San Isidro, Lima, emphasizing "Marketing and Development" (Desarrollos y Marqueting). Adding a digital layer that connects their marketing efforts with real-time safety and logistics data would position them as a more modern, tech-forward partner in the growing Peruvian pharmaceutical market.
DIGEMID - General Directorate of Medicines, Supplies and Drugs Since specific details regarding your personal experience (e
The Peruvian pharmaceutical market is projected to grow at a CAGR of 5–7% through 2030, driven by an aging population, rising chronic disease prevalence, and expanded healthcare coverage under Universal Health Insurance (SIS). For D amp M Pharma Peru SAC, several growth avenues exist:
If the company successfully secures more DIGEMID authorizations for advanced therapies (e.g., gene therapy vectors or monoclonal antibodies), it could ascend from a mid-tier wholesaler to a specialty logistics leader.
D & M Pharma Peru S.A.C. appears to be a formally registered Peruvian closed corporation in the pharmaceutical sector. However, the name alone does not guarantee reliability, compliance with health regulations, or financial solvency. In Peru’s pharmaceutical market, strict regulatory oversight by DIGEMID and SUNAT is the norm—but not all companies adhere to it.
Always perform independent third-party verification before any transaction involving drugs, medical devices, or health-related products. Counterfeit and unregulated medicines remain a serious risk in emerging markets, including Peru.
Disclaimer: This post is for informational purposes only and does not constitute legal, financial, or professional due diligence. Laws and corporate statuses change. Always consult with a local Peruvian attorney or a registered business information service before making commercial decisions.
D&M Pharma Perú S.A.C. is a specialized pharmaceutical company based in Lima, Peru, that focuses on the distribution and marketing of high-quality therapeutic solutions. Established in 2006, the company acts as a strategic gateway for international pharmaceutical lines—most notably the Argentine Laboratorio Cassará —to reach the Peruvian healthcare market. Corporate Identity and Strategic Origins
D&M Pharma (short for "Desarrollos y Marketing Farmacéutico") was originally founded in Chile in 2003 by executives with extensive industry expertise. International Partnership:
In 2005, the company formed a partnership with Laboratorio Cassará, a prestigious Argentine laboratory with over 75 years of experience. Peruvian Launch: The company officially began operations in Peru in August 2007
(though its presence dates to 2006) to consolidate its international reach through the Cassará line. Current Scale: Reliable supply chain and logistics
As of late 2024, the enterprise operates with a team of approximately 32 employees out of its headquarters in San Isidro, Lima Therapeutic Specializations
The company’s portfolio is defined by its collaboration with various specialized divisions, providing medical professionals and patients with targeted treatments: Respiratory & Aerosol Therapy:
Recognized across Latin America for advanced treatments in asthma and other pulmonary conditions. Dermatology: Through divisions like Fouchard, Bailleul, and Feelderm
, they offer specialized skin care and clinical dermatological products. Ophthalmology: Managed under the Biotecnología:
Integration of biotechnology into their medicinal development, particularly through the Cassará division. Regulatory Compliance & Quality Standards
D&M Pharma Perú operates under strict adherence to national and international pharmaceutical standards. Standards: They follow the Good Storage Practices (BPA)
and technical norms established by the Peruvian Ministry of Health. Pharmacovigilance:
The company maintains robust drug safety protocols to monitor and report adverse events to the (the Peruvian regulatory authority). Recent Leadership & Recognition
The company continues to hold a significant voice in the Peruvian health sector. Notably, in April 2026 , the company's Technical Director, Dra. Mery Luz Peña García
, was elected as Vice President of the Medicines Sector Board for the COMSALUD Gremio de Salud of the Lima Chamber of Commerce. or information on how to contact their regulatory department D & M Pharma Peru S.A.C. Company Profile - EMIS 31-Oct-2024 —